Table 4.
Metformin/Sulphonylurea | Insulin | |||||||
---|---|---|---|---|---|---|---|---|
2 years prior to ADT initiation | 2 years after ADT initiation | 2 years prior to ADT initiation |
2 years after
ADT initiation |
|||||
Type of ADT at initiation |
No DM
events |
Incidence of DM |
No DM
events |
Incidence of DM |
No DM
events |
Incidence of DM |
No DM
events |
Incidence of DM |
All | 394 | 10.4 | 301 | 10.1 | 73 | 1.9 | 113 | 3.8 |
AA | 128 | 9.1 | 91 | 8.1 | 21 | 1.5 | 19 | 1.7 |
AA initial treatment | 50 | 9.2 | 44 | 9.5 | 10 | 1.8 | 10 | 2.2 |
AA deferred treatment | 78 | 9.0 | 47 | 7.1 | 11 | 1.3 | 9 | 1.4 |
GNRH | 266 | 11.1 | 210 | 11.3 | 52 | 2.2 | 94 | 5.0 |
GNRH initial treatment | 195 | 10.9 | 159 | 11.3 | 41 | 2.3 | 70 | 5.0 |
GNRH deferredtreatment | 71 | 11.7 | 51 | 11.2 | 11 | 1.8 | 24 | 5.2 |